Dr. Leen Kawas, an accomplished professional in the field of bioscience, has channeled her passion for this discipline into a diverse and multifaceted career. With a commitment to making positive impacts through her work, Leen Kawas continues to inspire and lead in various roles. One notable aspect of Dr. Leen Kawas's career is her dedication to innovative research and development. Her contributions to bioscience have been instrumental in...
Leen Kawas, a prominent figure in the biotech industry, recently shared valuable insights on actionable steps for women to overcome barriers and break the glass ceiling in the field. In her interview with The Daily UW, Leen Kawas highlighted the significance of mentorship, self-advocacy, and perseverance. Mentorship plays a pivotal role in empowering women in biotech. Kawas emphasized the importance of seeking out mentors who can provide...
Dr. Leen Kawas Biological Insights at RBC Capital Markets Meeting Dr. Leen Kawas provided insights and actionable intelligence at the February 2023 RBC Capital Markets Meeting, which was held to analyze the recent sluggishness experienced by biotech markets. Recently, the industry has begun regaining its commercial success due to efforts by stronger biotech firms that resisted the downturn - like Kawas’s company, Propel Bio Partners. Many of...
Leen Kawas Speaks About Her Exit from Athira Leen Kawas is a managing partner of Propel Bio Partners, a firm dedicated to transforming the Biotech industry. Before launching Propel Bio Partners, Leen Kawas was the CEO of Athira Pharma. She resigned from Athira in October 2021 due to controversies. Resigning from Athira Leen Kawas faced controversial issues arising from her doctoral work as a student. The issue was that her work contained altered...